Company news

CLEO Diagnostics Ltd news in 2024

CLEO Diagnostics Ltd's news releases, calls and decks from 2024, newest first.

View company

CLEO Further Expands Ovarian Cancer Trial with Siles Health

December 9, 2024

The Royal Women's Hospital Joins CLEO Ovarian Cancer Trial

November 26, 2024

Cleo Commences U.S. Clinical Trials

September 5, 2024

Appendix 4E and 2024 Annual Report

August 27, 2024

CLEO Selects U.S. Clinical Trial Sites

July 30, 2024

Cleo Commences US Regulatory Process with FDA

June 25, 2024

COV Ovarian Cancer Blood Test Outperforms Clinical Benchmark

May 28, 2024

COV Appoints CRO to Manage US Ovarian Cancer Clinical Trials

April 10, 2024

CLEO Appoints Partner to Commence U.S. Market Access Program

April 2, 2024

Peer-Review Supports CLEOs Ovarian Cancer Detection Tech

March 24, 2024

Cleo Completes Design Transfer

February 11, 2024

Decks in 2024